- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00564707
Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome
Comparison of Biofeedback Therapy and Botulinum Toxin Type A Injections for Treatment of Painful Levator Ani Syndrome in Women: A Randomized, Prospective Trial
Purpose: To assess whether EMG directed biofeedback therapy or Botulinum toxin type A injection of the levator ani muscles has any effect on pain from the levator ani syndrome, and, in addition, to what extent either treatment is superior to the other in terms of anorectal physiologic measurements, and quality of life.
Study Design: Randomized, prospective, unblinded double-armed study with crossover.
Methodology: Female subjects, aged 18 and over, with painful levator ani muscle spasm for at least one month duration will be randomized to receive either biofeedback therapy or Botulinum toxin type A injection. After randomization they will all undergo visual analog pain scoring, anorectal manometry, colonoscopy (if clinically indicated), and self-reported SF-36 quality of life measurement. Each patient will also complete numerical pain scale scoring, an SF-36, and a satisfaction questionnaire at each treatment visit and follow-up visit. Patients will submit these by mail. Identification numbers will be assigned to each subject for use on the SF-36 and Satisfaction Questionnaires throughout the study. Subjects will again undergo anorectal manometry at the end of their treatment arms. In the biofeedback arm patients will be treated biweekly for up to eight treatments and be provided exercises to practice at home based on their muscle function noted during the biofeedback training session. Subjects will keep a treatment diary of the exercises they do at home to help ensure compliance with the protocol. In the Botulinum toxin injection arm patients will be treated with scheduled injections of the levator ani muscles every six weeks for up to three total injections of 100U each. These injections will be directed to the painful areas of the levator muscles as guided by physical exam and EMG measurements. Should any patient fail their initial randomized treatment assignment (failure defined as "very dissatisfied" or "dissatisfied" on the satisfaction questionnaire), they will then be allowed to cross over to the other study arm. In addition to numerical pain scale scoring, an SF-36 questionnaire and anorectal manometry will also be repeated at the time of crossover. We intend to include all randomized patients in the final data analysis (according to their originally assigned treatment arm), regardless of outcome or reason for dropout, thus making this an "intent-to-treat" analysis.
Pivotal Study Definitions: The definition of adequate pain reduction, for the purposes of data analysis, will be a reduction in a subject's mean pain score of two on a numerical pain scale (0-10). Failure of either therapy will be defined as a response of "very dissatisfied" or "dissatisfied" on the satisfaction questionnaire at the end of either biofeedback (eight treatment visits) or Botulinum toxin (three injections) both before and after crossover.
Outcomes: We will determine the following for biofeedback therapy and Botulinum toxin type A injection: mean pain reduction, any differences in anorectal physiologic measurements (such as mean resting anal sphincter pressure), any changes in self-reported quality of life, and overall patient satisfaction.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jeffery M Nelson, MD
- Phone Number: 202-782-9691
- Email: Jeffery.Nelson@us.army.mil
Study Contact Backup
- Name: Todd Albright, MD
- Phone Number: 202-782-8518
- Email: Todd.Albright@na.amedd.army.mil
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20307
- Recruiting
- Walter Reed Army Medical Center
-
Principal Investigator:
- Jeffery M Nelson, MD
-
Sub-Investigator:
- Todd S Albright, MD
-
Sub-Investigator:
- Kendra L Harrington, DPT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients should be 18 years of age or older and capable of providing informed consent indicating awareness of the investigational nature of this trial.
- History of chronic anorectal pain from levator ani spasm three or more months in duration.
- Pain involves only the anorectum, and is part of one of the established variants of levator ani syndrome including spasm, coccygodynia, proctalgia fugax.
- Written informed consent must be obtained from each patient prior to entering the study.
- Female patients will not be pregnant. Exclusion of the possibility of pregnancy by HCG testing (urine or serum) or by history (tubal ligation, hysterectomy, or menopause) is required prior to inclusion in the study.
- Patients should be willing to be followed within the military healthcare system during the course of study treatment and follow-up. Follow-up at other military facilities is acceptable.
- Ability to follow study instructions and likely to complete all required visits.
Exclusion Criteria:
- Patients with current participation in another clinical investigation of a medical device or a drug the requirements of which may preclude complete involvement in this study
- Active or previous (within 60 days prior to the study screening visit) chemotherapy
- Active or previous (within 60 days prior to the study screening visit) radiation
- Physical or mental disability or geographical concerns (residence not within reasonable travel distance) that would hamper compliance with required study visits
- The Investigator believes that the subject will be unwilling or unable to comply with study protocol requirements
- Patients < 18 years of age
- Incapable of providing informed consent
- Subject has chronic (>3 months) vaginal pain not related to levator spasm
- Patients who are pregnant.
- Patients unwilling, or unable, to be followed within the military healthcare system during the course of study treatment and follow-up.
- Documented urinary tract infection
- Genitourinary (GU) or anorectal malignancy
- Undergoing Botulinum toxin injection therapy or biofeedback therapy at the time of enrollment
- Known allergy or sensitivity to any study medication (Botulinum toxin, lidocaine)
- History of infection with Human Immunodeficiency Virus
- History of immunodeficiency disorders
- Patients taking antibiotics at the time of study enrollment
- Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis, spinal cord injury or any other significant disease which might interfere with neuromuscular transmission.
- Concurrent use of agents that interfere with neuromuscular transmission
- Profound atrophy or excessive weakness on physical examination of the muscles to be injected with associated fecal incontinence
- Infection at the injection site
- Is overtly psychotic or suicidal.
- Anismus (inability to empty the rectum adequately during defecation) not associated with painful levator ani muscles
- History of anorectal or low pelvic surgery within the last year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1
Standard biofeedback therapy will be given for painful levator ani syndrome over a course of eight weeks.
|
EMG guided biofeedback therapy using standard biofeedback computer software
|
Active Comparator: 2
Botulinum toxin type A will be injected under EMG guidance into spastic and painful levator ani muscles.
This may be repeated only twice on separate visits.
|
Under EMG guidance Botox is injected directly into the painful levator ani muscle.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pain reduction from treatment with either Biofeedback, Botox injection, or both
Time Frame: Two years
|
Two years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Anorectal physiologic changes - increase or decrease in anal sphincter pressures
Time Frame: Two years
|
Two years
|
Overall patient satisfaction
Time Frame: Two years
|
Two years
|
Patient quality of life
Time Frame: Two years
|
Two years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jeffery M Nelson, MD, Walter Reed Army Medical Center
Study record dates
Study Major Dates
Study Start
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Metabolic Diseases
- Neurologic Manifestations
- Disease
- Signs and Symptoms, Digestive
- Gastrointestinal Diseases
- Genetic Diseases, Inborn
- Intestinal Diseases
- Rectal Diseases
- Metabolism, Inborn Errors
- Hyperbilirubinemia, Hereditary
- Syndrome
- Constipation
- Pain
- Anus Diseases
- Crigler-Najjar Syndrome
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Cholinergic Agents
- Membrane Transport Modulators
- Acetylcholine Release Inhibitors
- Neuromuscular Agents
- Botulinum Toxins
- Botulinum Toxins, Type A
- abobotulinumtoxinA
Other Study ID Numbers
- 07-20034
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Levator Ani Syndrome With Pain and/or Constipation Symptoms.
-
National Institute of Diabetes and Digestive and...University of North Carolina, Chapel HillCompletedChronic Proctalgia (Also Called Levator Ani Syndrome)Italy
-
Swedish Medical CenterWithdrawnLevator Ani SyndromeUnited States
-
Vanderbilt UniversityWithdrawnLevator Ani SyndromeUnited States
-
Azienda Sanitaria Universitaria Friuli CentraleNot yet recruitingPelvic Floor Disorders | Levator Ani SyndromeItaly
-
Orlando VA Medical CenterRecruitingPelvic Pain | Levator Ani Syndrome | Chronic Pelvic Pain Syndrome | Spastic Pelvic Floor Syndrome | Myalgia of Pelvic FloorUnited States
-
AstraZenecaPeking University First Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsCompletedIrritable Bowel Syndrome With Constipation | Functional ConstipationChina
-
AbbVieIronwood Pharmaceuticals, Inc.Enrolling by invitationIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Canada, Israel, Netherlands
-
Vasily IsakovRussian Science Foundation; Azbuka vkusa; Federal Research Centre of Nutrition...CompletedIrritable Bowel Syndrome With Constipation | Constipation-predominant Irritable Bowel SyndromeRussian Federation
-
Federal Stare Budgetary Scientific Institution,...I.M. Sechenov First Moscow State Medical University; RML INVEST, Torkhovsky...CompletedIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedRussian Federation
-
Ironwood Pharmaceuticals, Inc.Forest LaboratoriesCompletedIrritable Bowel Syndrome With Constipation | Chronic ConstipationUnited States
Clinical Trials on Biofeedback therapy
-
Augusta UniversityCompleted
-
Augusta UniversityNational Institutes of Health (NIH)CompletedConstipation | Dyssynergia
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin BranchCompletedPanic Disorder | Feedback, PsychologicalTaiwan
-
Washington University School of MedicineEnrolling by invitationVocal Cord Dysfunction | Paradoxical Vocal Fold MotionUnited States
-
University of AlcalaCompleted
-
University of California, San DiegoUnknown
-
University of NottinghamNational Institute for Health Research, United KingdomCompletedStroke, Acute | Dysphagia, OropharyngealUnited Kingdom
-
National Taiwan University HospitalRecruitingSomatic Symptom DisorderTaiwan
-
National Institute for Locomotor Disabilities (Divyangjan)...Recruiting
-
Taibah UniversityCompletedBladder Dysfunction on Patients With Multiple SclerosisSaudi Arabia